In the July 1, 2006, issue of Blood , Meshinchi et al[1][1] comment on the role of stem-cell transplantation (SCT) in FLT3/ITD-positive acute myeloid leukemia (AML). In their interpretation of data previously presented by Gale et al,[2][2] they conclude that the occurrence of a FLT3/ITD may not be
No takes yet. Share an insight, caveat, or question.
Bornhäuser et al. (2007) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: